ABSTRACT
BACKGROUND: Gastric cancer (GC) is the leading cause of cancer death in Peru. However, information regarding trends in mortality rates in Peru and its geographical areas in the last few decades is lacking. Our objective was to describe GC mortality rates in Peru between 2005 and 2020. METHODS: Age standardized mortality rates (ASMR) were calculated per 100,000 person-years using the world SEGI standard population. Joinpoint regression analysis was performed to examine mortality trends. The analysis of the last 5 years was performed for Peru and its geographical areas. RESULTS: GC mortality rates in 2005 and in 2020 were 13.81 and 10.52, respectively, for men and 11.81 and 8.06, respectively, for women. Between 2016 and 2020, Huanuco and Huancavelica reported the highest mortality rates (≥20 deaths per 100,000). In men, Peru and the highlands region reported significant decreases in GC mortality rates in both sexes for some periods. Coastal region significant decreased by 2.6 % in all periods for women. In both sexes, six provinces reported significant decreases in GC mortality rates. CONCLUSION: Although GC mortality rates in Peru have declined over the past 16 years. They are still one of the highest in the Latin American and Caribbean region. It is important that the Peruvian State seek to reduce the mortality of this disease through prevention efforts, timely detection and treatment in all patients.
Subject(s)
Stomach Neoplasms , Male , Humans , Female , Stomach Neoplasms/epidemiology , Peru/epidemiology , Racial Groups , Caribbean Region , MortalityABSTRACT
Hemos leído con sumo interés el artículo "Un nuevo coronavirus, una nueva enfermedad: COVID-19" de Pareja, et. al. donde observamos que las repercusiones que trae la pandemia, dejan en clara evidencia la limitada experiencia que se tiene. La telemedicina (TM) se ha convertido en una herramienta tecnológica para llevar atención médica y que tiene mucho potencial en escenarios donde la infraestructura se encuentra intacta y los médicos están disponibles a la atención. De esta manera, se minimiza la exposición, teniendo en cuenta que gran parte de los contagios se produjeron en los hospitales.
We have read with great interest the article "A new coronavirus, a new disease: COVID-19" by Pareja, et. al. where we observe that the repercussions bringing with pandemic, evidence the limited experience we have. Telemedicine (TM) has become a technological tool to provide medical care and a tool with great potential in settings where the infrastructure is intact and doctors are available for care. In this way, exposure is minimized, taking into account that number of infections occurred in hospitals was gargantuan.